MASLD: A Metabolic Disease with Growing Cardiovascular Impact
Introduction Metabolic dysfunction-associated steatotic liver disease (MASLD), formerly known as non-alcoholic fatty liver disease (NAFLD), has become one of the fastest-growing metabolic disorders worldwide.Its prevalence is rising in parallel with obesity, type 2 diabetes, and metabolic syndrome, affecting millions of people globally. Although traditionally considered a liver disease, increasing evidence suggests that MASLD has significant […]